Form D · Pharmaceuticals
Terns Pharmaceuticals, Inc.
Foster City, CA · CIK 0001831363
Offering snapshot reported Jan 7, 2021 · SEC filing
- Reported sold
- $97.7M Offering amount: $97.7M
- Investors reported
- 13 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Dec 29, 2020 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jan 7, 2021 | Initial | $97,703,068 | No comparison | 13 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-385533
Source: Form D, filed Jan 7, 2021. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| David Fellows | Director |
| Carl Gordon, Ph.D. | Director |
| Jeffrey Kindler | Director |
| Hongbo Lu, Ph.D. | Director |
| Jill Quigley | Director |
| Yi Shi, Ph.D. | Director |
| Senthil Sundaram | Director, Executive |
| Mark Vignola, Ph.D. | Executive |
| Elise Wang | Director |
| Bryan Yoon | Executive |
| Weidong Zhong, Ph.D. | Director, Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
1065 East Hillsdale Blvd., Suite 100
Foster City, CA, 94404
Foster City, CA, 94404